HRT Shortage in the UK: 60% of Women Struggle to Access Menopause Medication as Supply Crisis Continues

UK HRT shortages are leaving women struggling to access menopause treatment. Discover why supplies are limited, which alternatives may be available and what to do if your prescription is out of stock.

HRT Shortages Leave Thousands of Women Facing Treatment Disruption

Women across the UK are continuing to experience difficulties accessing hormone replacement therapy (HRT), with new research highlighting the impact of ongoing medicine shortages on menopause care.

According to research commissioned by online pharmacy Pharmacy2U, 61% of women surveyed said they had needed to make at least a second trip to their pharmacy after being unable to collect their prescribed menopause medication on their first visit. Around one-third reported visiting multiple pharmacies to find their treatment.

The findings underline growing concerns about the availability of essential medicines and the challenges faced by women who rely on HRT to manage menopause symptoms.

Certain strengths of Estradot patches have experienced supply problems since late 2024. Shortages affecting several strengths have been subject to official notices, with availability not expected to fully recover until 2027 in some cases.

For women who depend on regular treatment, these disruptions can cause uncertainty, additional expense and anxiety about the return of uncomfortable symptoms.

Why Is There an HRT Shortage in the UK?

HRT is widely prescribed to help manage symptoms associated with perimenopause and menopause. Treatment can help reduce hot flushes, night sweats, sleep disturbances, mood changes and other symptoms that may affect daily life.

Demand for menopause treatment has increased significantly in recent years. The report cited by Pharmacy2U highlights the growing number of women receiving prescribed HRT, putting additional pressure on medicine supply chains.

However, increased demand is only one factor that may contribute to shortages. Manufacturing capacity, distribution difficulties and changes in demand for particular formulations can also affect availability.

The shortage has been particularly concerning for women prescribed Estradot patches in specific strengths, including 25, 50, 75 and 100 micrograms per 24 hours. Official shortage arrangements have been introduced for certain products to help pharmacists manage limited supplies.

FemSeven Conti patches have also faced supply problems, with a notice published in October 2026 indicating that the product was expected to remain unavailable until late November 2026. These dates can change, so patients and healthcare professionals should check the latest official guidance.

How Are the Shortages Affecting Women?

The impact extends beyond the inconvenience of making another pharmacy visit.

In the Pharmacy2U survey, 44% of women with repeat prescriptions for HRT or other menopause treatments said they had noticed fewer medicines available at their local pharmacy over the previous 12 months.

Two in five respondents reported feeling stressed because their HRT was unavailable, while 15% said the situation had contributed to health problems.

When HRT treatment is interrupted, some women may experience a return of symptoms such as hot flushes, night sweats, anxiety, low mood, poor sleep and difficulty concentrating. The effect varies depending on the individual, their treatment and their underlying health circumstances.

Healthcare professionals have warned women against reducing their doses, rationing patches or changing how they use medication without medical advice.

Maintaining continuity of treatment is desirable when possible, but the most appropriate response to a shortage depends on the prescribed product and the patient's individual needs.

What Should You Do If Your HRT Prescription Is Out of Stock?

If your usual HRT medication is unavailable, there are several practical steps you can take.

1. Speak to your pharmacist

Contact your pharmacy before making another journey to check whether your prescribed medicine is available or when new supplies are expected.

Ask whether an alternative formulation or an equivalent-strength product may be suitable. Pharmacists can explain the options available under current NHS guidance and any applicable Serious Shortage Protocol.

These protocols can permit the supply of specified alternatives in certain circumstances without requiring a new prescription from your GP. However, they do not apply automatically to every medicine or patient.

2. Contact your GP or menopause specialist

If your usual medication cannot be obtained, contact your GP or prescribing clinician for advice.

Depending on your circumstances, they may recommend a different HRT brand, formulation, dose or method of administration. Available alternatives can include other patches, gels, sprays or tablets, although not every option will be appropriate for every patient.

For example, other combined HRT patches may be available when a particular product is in short supply. However, products can contain different hormones and strengths, so they should not be treated as interchangeable without professional guidance.

3. Check availability before visiting pharmacies

Medicine stock can vary between pharmacies and locations. Calling ahead or using a reputable pharmacy's medicine stock-checking service may help you identify potential availability before travelling.

Online pharmacies may also provide information about stock levels, although availability can change quickly and a stock listing does not guarantee that a prescription can be supplied.

4. Do not change your treatment yourself

Avoid cutting patches, reducing doses, extending the time between applications or switching to another person's medication to make supplies last longer.

These changes may affect how much medicine you receive and whether your treatment remains appropriate. If you are running low, seek advice from your pharmacist or prescriber as early as possible.

If you have already missed doses and are experiencing returning symptoms, explain this to your healthcare professional so they can advise you on the safest next step.

HRT Is Not the Only Medicine Facing Supply Problems

The wider UK medicine shortage situation has also affected other treatments.

Medicines reported as experiencing supply difficulties include certain strengths of ramipril, used to treat high blood pressure and some heart conditions, and edoxaban, an anticoagulant used to help prevent blood clots.

Other products listed in shortage notices have included some formulations of venlafaxine, quetiapine, lansoprazole and Creon, alongside selected eye drops and bowel preparation medicines.

The availability of these products can vary according to strength, formulation, location and date. A medicine appearing on a shortage list does not necessarily mean that every version is unavailable.

Patients taking regular medication should speak to their pharmacist or prescriber if they encounter difficulties obtaining a prescription. Do not stop taking essential medicines without professional advice.

What Does the Future Look Like for HRT Availability?

The ongoing HRT shortage highlights the importance of reliable medicine supplies as demand for menopause care grows.

Healthcare professionals have called for supply chains to keep pace with the increasing number of women seeking support for menopause symptoms. In the meantime, official shortage notices, pharmacy guidance and clinically appropriate alternatives can help patients navigate interruptions.

Women experiencing menopause symptoms should not feel they have to manage treatment disruptions alone. Pharmacists, GPs and specialist menopause services can help identify suitable options and explain how to maintain treatment safely.

If your usual HRT is unavailable, act early, check current advice and seek professional guidance rather than making changes independently.

Frequently Asked Questions

How long will the UK HRT shortage last?

The duration varies by product and strength. Some Estradot shortage notices extend into early 2027, while FemSeven Conti was reported as unavailable until late November 2026. These are expected dates, not guarantees, and should be checked against the latest official updates.

Can a pharmacist give me an alternative to Estradot?

In certain circumstances, a pharmacist may be able to supply an alternative under an applicable Serious Shortage Protocol. Otherwise, you may need advice or a revised prescription from your GP or prescriber.

What happens if I run out of HRT?

Some menopause symptoms may return if treatment is interrupted. Contact your pharmacist or prescriber promptly for individual advice, especially if you are already experiencing symptoms.

Can I switch to another HRT brand?

Potentially, but different products can contain different hormones, doses and delivery systems. A pharmacist or prescriber should confirm which alternative is suitable for you.

Sources

• Pharmacy2U, survey findings on women's experiences accessing HRT and menopause medication, as reported in the source article published on 14 October 2026 and updated on 15 October 2026.
• UK Department of Health and Social Care (DHSC), medicine supply and Serious Shortage Protocol notices.
• British Menopause Society (BMS), guidance and information on HRT and menopause treatment.

Disclaimer: This article is for general information and educational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. Medicine availability and shortage arrangements may change. Always consult your pharmacist, GP or prescribing clinician before changing, stopping or substituting HRT or any other prescribed medicine.